Daily inpatient ertapenem therapy can be an alternative to hospitalization for the treatment of complicated urinary tract infections during the COVID‐19 pandemic-Reference-Cited by-同舟云学术

Daily inpatient ertapenem therapy can be an alternative to hospitalization for the treatment of complicated urinary tract infections during the COVID‐19 pandemic

Published:2021-04-20 Issue:7 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Nazli Zeka Arzu¹^ORCID,Avkan‐Oguz Vildan²,Irmak Caglar²,Eren Kutsoylu Oya¹,Alp Cavus Sema²,Kuruüzüm Ziya²,Ergon M. Cem³

Affiliation:

1. Infectious Diseases and Clinical Microbiology Faculty of Medicine Dokuz Eylül University Izmir Turkey

2. Infectious Diseases and Clinical Microbiology Dokuz Eylul Universitesi Tip Fakultesi Izmir Turkey

3. Medical Microbiology Dokuz Eylul University Faculty of Medicine Izmir Turkey

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14230

Reference30 articles.

1. Epidemiology and susceptibility of pathogens from SMART 2011–12 Turkey: evaluation of hospital‐acquired versus community‐acquired urinary tract infections and ICU‐ versus non‐ICU‐associated intra‐abdominal infections;Koksal I;J Antimicrob Chemother,2017

2. Extended-Spectrum Beta-Lactamase Production by Enterobacteriaceae Isolates From Urine Cultures of Outpatients: Results of a 7-Year Follow-Up

3. Antibiotic Resistance Patterns of Escherichia coli Strains Isolated from Urine Cultures in Turkey: A Meta-Analysis

4. Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species

5. Hospital-acquired urinary tract infection point prevalence in Turkey: Differences in risk factors among patient groups

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network;Global and Regional Health Technology Assessment;2024-07-29

2. Ecofriendly bioanalytical validated RP-HPLC method for simultaneous determination of COVID-19 co-prescribed drugs employing quality by design and green chemistry;Microchemical Journal;2024-05

3. HPLC/UV approach method for the first simultaneous estimation of molnupiravir and ertapenem as a binary mixture in human plasma and dosage form as a regimen for COVID-19 treatments;BMC Chemistry;2023-09-21

4. Pivmecillinam with Amoxicillin/Clavulanic acid as step down oral therapy in febrile Urinary Tract Infections caused by ESBL-producing Enterobacterales (PACUTI);Trials;2023-09-02

5. Pivmecillinam with Amoxicillin/Clavulanic acid as Step Down Oral Therapy in Febrile Urinary Tract Infections Caused by ESBL-producing Enterobacterales (PACUTI);2023-02-17